CMK Corporation provided consolidated earnings guidance for the year ending March 31, 2024. For the year, the company expects net sales of JPY 87,000 million, operating income of JPY 3,200 million, profit attributable to owners of parent of JPY 2,000 million and net income per share of JPY 33.70.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
624 JPY | +2.97% | +4.70% | -24.82% |
28/02 | Aurora Cannabis Teams Up With Script Assist to Provide Access to UK Medical Cannabis; Down 1.8% | MT |
28/02 | Aurora Cannabis Teams Up With Script Assist to Provide Access to UK Medical Cannabis | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.82% | 262M | |
+9.85% | 53.68B | |
-16.47% | 14.79B | |
+13.54% | 11.02B | |
+5.97% | 8.92B | |
+24.55% | 8.7B | |
+44.03% | 8.31B | |
-9.56% | 8.12B | |
-14.29% | 6.93B | |
-12.10% | 6.92B |
- Stock Market
- Equities
- 6958 Stock
- News CMK Corporation
- CMK Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024